Investigating the functional role of CD2BP2 in T cells

Matthias Heinze1, Michael Kofler, Christian Freund

  • 1Protein Engineering Group, Leibniz-Institute of Molecular Pharmacology and Free University Berlin, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.

International Immunology
|October 2, 2007
PubMed

Insights

The adaptor protein CD2-binding protein 2 (CD2BP2) binds to proline-rich sequences. This study found CD2BP2

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • The adaptor protein CD2-binding protein 2 (CD2BP2) interacts with proline-rich sequences (PRS) through its GYF domain.
  • While CD2BP2 binds to the cytoplasmic domain of CD2 and other proteins, its in vivo relevance remains unclear.

Purpose of the Study:

  • To investigate the in vivo significance of CD2BP2 interactions, particularly its role in CD2 signaling and cytokine production.
  • To determine if other PRS compete with CD2 for CD2BP2 binding in the nucleus.

Main Methods:

  • Co-expression of CD2 and CD2BP2 in HeLa cells to assess nuclear localization.
  • Knockdown of CD2BP2 in peripheral blood mononuclear cells (PBMCs) using small interfering RNA (siRNA).
  • Measurement of T-cell cytokine expression following CD2BP2 knockdown.

Main Results:

  • CD2BP2 nuclear localization was unaffected by co-expression with CD2, suggesting competition from other PRS.
  • CD2BP2 knockdown in PBMCs did not significantly alter T-cell cytokine expression.
  • These findings indicate that CD2 signaling is not entirely dependent on CD2BP2.

Conclusions:

  • CD2BP2's interaction with CD2 is context-dependent, with other PRS playing a competitive role in the nucleus.
  • CD2 signaling in primary immune cells appears to be largely independent of CD2BP2.
  • The study clarifies the in vivo role of CD2BP2 in CD2-mediated signaling pathways.